Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR Augmentation in Depression
NCT00296517Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in major depressive disorder (MDD), sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00296517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296517.